In Vitro Drug Release and Hemocompatibility of Biodegradable Plga/Peg Coated Paclitaxel-Eluting Stents

Article Preview

Abstract:

The Paclitaxel-eluting stents (PTX) with biodegradable copolymer coating were studied in investigations. The polymer blend composition of PLGA (polylactic acid-co-glycolic acid) and PEG (poly ethylene glycol) have been applied as drug carrier and fabricated on the surface of 316L stainless steel stents by ultrasonic atomization spraying method. Were explored three doses: low-dose (~80μg per stent, 10 wt%), moderate-dose (~150μg per stent , 20 wt%), and high-dose (~220μg per stent , 30 wt%). The weight ratio of Paclitaxel to PLGA/PEG blends was 10:90, 20:80, and 30:70. Pre- and post-expansion surface morphologies of the Paclitaxel-eluting copolymer coating stents were examined by scanning electron microscopy (SEM). The quantitative analysis of Paclitaxel release in vitro and hemocompatibility by hemolysis ratio and dynamic clotting time measurement also were investigated.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

49-53

Citation:

Online since:

January 2013

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2013 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] D.M. Martin, F.J. Boyle:J. Medical Engineering & Physics 33 (2011) 148-163.

Google Scholar

[2] J. Ako, H.N. Bonneau, Y. Honda and P.J. Fitzgerald: Am. J. Cardiol. 100 (8B) (2007) 3M-9M.

Google Scholar

[3] J.E. Puskas, L.G. Munoz-Robledo, R.A. Hoerr, et al., : Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1 (4) (2009) 451-462.

Google Scholar

[4] J.E. Moore Jr.:J. Endovasc. Ther. 16 (1) (2009) 1-11.

Google Scholar

[5] E. Grube, U. Gerckens, R. Muller and L. Bullesfeld:J. Kardiol. 91 (3) (2002) 44-48.

Google Scholar

[6] A.W. Heldman, L. Cheng, G.M. Jenkins et al.:J. Circulation. 103 (2001) 2289-2295.

Google Scholar

[7] C. Herdeg, M. Oberhoff, A. Baumbach et al.: J. Am. Coll Cardiol. 35 (2000) 1969-(1976).

Google Scholar

[8] W.L. Hunter, H.M. Burt and L. Machan: J. Ad. Drug Delivery Rev. 26 (1997) 199-207.

Google Scholar

[9] G.W. Stone, S.G. Ellis, D.A. Cox et al:N. Engl. J. Med. 3 (2004) 221-231.

Google Scholar

[10] J.M. Harris, Introduction to biotechnical and biomedical applications of poly(ethylene glycol), in: J.M. Harris (Ed. ), Poly(ethylene glycol) Chemistry, Biotech. And Biomed. Applications, Plenum Press, New York, (1992).

DOI: 10.1007/978-1-4899-0703-5_1

Google Scholar

[11] A.A. Ignatius, L.E. Claes:J. Biomaterials 17 (1996) 831-839.

Google Scholar

[12] X.S. Wu, Synthesis and properties of biodegradable lactic/glycolic acid polymers, in: D.L. Wise with coauthors Handbook of Biomaterials and Bioengineering, Part A: Materials, Marcel Dekker, New York, (1995).

Google Scholar

[13] Li Li, HongTao Sun and YuFeng Zheng, CN 101, 279, 111. (2011).

Google Scholar